About 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide
2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide (PubChem CID 123162243) has the molecular formula C34H42FN5O4
and a molecular weight of 603.74 g/mol. Its IUPAC name is 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide.
Molecular Properties
| Compound Name | 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide |
| PubChem CID | 123162243 |
| Molecular Formula | C34H42FN5O4 |
| Molecular Weight | 603.74 g/mol |
| Exact Mass | 603.32 |
| IUPAC Name | 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide |
| SMILES | CC1CC(=O)N(Cc2cc(F)c(C(=O)NC3CCN(CCCO)CC3)cc2Oc2ccc(-c3ccc(C(C)C)nn3)cc2)C1 |
| InChI | InChI=1S/C34H42FN5O4/c1-22(2)30-9-10-31(38-37-30)24-5-7-27(8-6-24)44-32-19-28(29(35)18-25(32)21-40-20-23(3)17-33(40)42)34(43)36-26-11-14-39(15-12-26)13-4-16-41/h5-10,18-19,22-23,26,41H,4,11-17,20-21H2,1-3H3,(H,36,43) |
| InChIKey | RDTFEZVJJXDGFJ-UHFFFAOYSA-N |
| XLogP | 5.14 |
| TPSA | 107.89 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 603.74 |
| LogP ≤ 5 | 5.14 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
The IUPAC name of 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide (CID 123162243) is 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide.
What is the SMILES notation for 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
The canonical SMILES for 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide is CC1CC(=O)N(Cc2cc(F)c(C(=O)NC3CCN(CCCO)CC3)cc2Oc2ccc(-c3ccc(C(C)C)nn3)cc2)C1.
What is the InChIKey of 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
The InChIKey is RDTFEZVJJXDGFJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H42FN5O4/c1-22(2)30-9-10-31(38-37-30)24-5-7-27(8-6-24)44-32-19-28(29(35)18-25(32)21-40-20-23(3)17-33(40)42)34(43)36-26-11-14-39(15-12-26)13-4-16-41/h5-10,18-19,22-23,26,41H,4,11-17,20-21H2,1-3H3,(H,36,43).
What are the key properties of 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide?
2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide has a molecular weight of 603.74 g/mol, XLogP of 5.14, 11 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-fluoro-N-[1-(3-hydroxypropyl)piperidin-4-yl]-4-[(4-methyl-2-oxopyrrolidin-1-yl)methyl]-5-[4-(6-propan-2-ylpyridazin-3-yl)phenoxy]benzamide is sourced from PubChem (CID 123162243), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).